 | • レポートコード：QYR9ST00775 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の抗体薬物コンジュゲート市場について調査・分析し、以下の構成でお届け致します。抗体薬物コンジュゲートの種類別には、アドセトリス、カドシラに、用途別には、乳癌、リンパ腫に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別抗体薬物コンジュゲート売上データ ・地域別抗体薬物コンジュゲート市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別抗体薬物コンジュゲート市場規模：アドセトリス、カドシラ ・用途別抗体薬物コンジュゲート市場規模：乳癌、リンパ腫 ・主要メーカーの企業情報：F. Hoffman-La Roche、Novartis AG、Takeda Pharmaceutical、Pfizer、Seattle Genetics、Genentech、Immunogen、Progenics Pharmaceuticals、Bayer Healthcare Pharmaceuticals ・抗体薬物コンジュゲートの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market.
The global Antibody Drug Conjugates market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibody Drug Conjugates market based on company, product type, end user and key regions.
This report studies the global market size of Antibody Drug Conjugates in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibody Drug Conjugates in these regions.
This research report categorizes the global Antibody Drug Conjugates market by top players/brands, region, type and end user. This report also studies the global Antibody Drug Conjugates market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
F. Hoffman-La Roche
Novartis AG
Takeda Pharmaceutical
Pfizer
Seattle Genetics
Genentech
Immunogen
Progenics Pharmaceuticals
Bayer Healthcare Pharmaceuticals
Market size by Product
Adcetris
Kadcyla
Market size by End User
Breast Cancer
Lymphoma
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antibody Drug Conjugates market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antibody Drug Conjugates market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antibody Drug Conjugates companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antibody Drug Conjugates submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antibody Drug Conjugates are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibody Drug Conjugates market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Antibody Drug Conjugates Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antibody Drug Conjugates Market Size Growth Rate by Product
1.4.2 Adcetris
1.4.3 Kadcyla
1.5 Market by End User
1.5.1 Global Antibody Drug Conjugates Market Size Growth Rate by End User
1.5.2 Breast Cancer
1.5.3 Lymphoma
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibody Drug Conjugates Market Size
2.1.1 Global Antibody Drug Conjugates Revenue 2014-2025
2.1.2 Global Antibody Drug Conjugates Sales 2014-2025
2.2 Antibody Drug Conjugates Growth Rate by Regions
2.2.1 Global Antibody Drug Conjugates Sales by Regions
2.2.2 Global Antibody Drug Conjugates Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antibody Drug Conjugates Sales by Manufacturers
3.1.1 Antibody Drug Conjugates Sales by Manufacturers
3.1.2 Antibody Drug Conjugates Sales Market Share by Manufacturers
3.1.3 Global Antibody Drug Conjugates Market Concentration Ratio (CR5 and HHI)
3.2 Antibody Drug Conjugates Revenue by Manufacturers
3.2.1 Antibody Drug Conjugates Revenue by Manufacturers (2014-2019)
3.2.2 Antibody Drug Conjugates Revenue Share by Manufacturers (2014-2019)
3.3 Antibody Drug Conjugates Price by Manufacturers
3.4 Antibody Drug Conjugates Manufacturing Base Distribution, Product Types
3.4.1 Antibody Drug Conjugates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody Drug Conjugates Product Type
3.4.3 Date of International Manufacturers Enter into Antibody Drug Conjugates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Antibody Drug Conjugates Sales by Product
4.2 Global Antibody Drug Conjugates Revenue by Product
4.3 Antibody Drug Conjugates Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Antibody Drug Conjugates Breakdown Data by End User
6 North America
6.1 North America Antibody Drug Conjugates by Countries
6.1.1 North America Antibody Drug Conjugates Sales by Countries
6.1.2 North America Antibody Drug Conjugates Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antibody Drug Conjugates by Product
6.3 North America Antibody Drug Conjugates by End User
7 Europe
7.1 Europe Antibody Drug Conjugates by Countries
7.1.1 Europe Antibody Drug Conjugates Sales by Countries
7.1.2 Europe Antibody Drug Conjugates Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibody Drug Conjugates by Product
7.3 Europe Antibody Drug Conjugates by End User
8 Asia Pacific
8.1 Asia Pacific Antibody Drug Conjugates by Countries
8.1.1 Asia Pacific Antibody Drug Conjugates Sales by Countries
8.1.2 Asia Pacific Antibody Drug Conjugates Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antibody Drug Conjugates by Product
8.3 Asia Pacific Antibody Drug Conjugates by End User
9 Central & South America
9.1 Central & South America Antibody Drug Conjugates by Countries
9.1.1 Central & South America Antibody Drug Conjugates Sales by Countries
9.1.2 Central & South America Antibody Drug Conjugates Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antibody Drug Conjugates by Product
9.3 Central & South America Antibody Drug Conjugates by End User
10 Middle East and Africa
10.1 Middle East and Africa Antibody Drug Conjugates by Countries
10.1.1 Middle East and Africa Antibody Drug Conjugates Sales by Countries
10.1.2 Middle East and Africa Antibody Drug Conjugates Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antibody Drug Conjugates by Product
10.3 Middle East and Africa Antibody Drug Conjugates by End User
11 Company Profiles
11.1 F. Hoffman-La Roche
11.1.1 F. Hoffman-La Roche Company Details
11.1.2 Company Business Overview
11.1.3 F. Hoffman-La Roche Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.1.4 F. Hoffman-La Roche Antibody Drug Conjugates Products Offered
11.1.5 F. Hoffman-La Roche Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Company Business Overview
11.2.3 Novartis AG Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis AG Antibody Drug Conjugates Products Offered
11.2.5 Novartis AG Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Company Business Overview
11.3.3 Takeda Pharmaceutical Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Takeda Pharmaceutical Antibody Drug Conjugates Products Offered
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Antibody Drug Conjugates Products Offered
11.4.5 Pfizer Recent Development
11.5 Seattle Genetics
11.5.1 Seattle Genetics Company Details
11.5.2 Company Business Overview
11.5.3 Seattle Genetics Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Seattle Genetics Antibody Drug Conjugates Products Offered
11.5.5 Seattle Genetics Recent Development
11.6 Genentech
11.6.1 Genentech Company Details
11.6.2 Company Business Overview
11.6.3 Genentech Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Genentech Antibody Drug Conjugates Products Offered
11.6.5 Genentech Recent Development
11.7 Immunogen
11.7.1 Immunogen Company Details
11.7.2 Company Business Overview
11.7.3 Immunogen Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Immunogen Antibody Drug Conjugates Products Offered
11.7.5 Immunogen Recent Development
11.8 Progenics Pharmaceuticals
11.8.1 Progenics Pharmaceuticals Company Details
11.8.2 Company Business Overview
11.8.3 Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Progenics Pharmaceuticals Antibody Drug Conjugates Products Offered
11.8.5 Progenics Pharmaceuticals Recent Development
11.9 Bayer Healthcare Pharmaceuticals
11.9.1 Bayer Healthcare Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Products Offered
11.9.5 Bayer Healthcare Pharmaceuticals Recent Development
12 Future Forecast
12.1 Antibody Drug Conjugates Market Forecast by Regions
12.1.1 Global Antibody Drug Conjugates Sales Forecast by Regions 2019-2025
12.1.2 Global Antibody Drug Conjugates Revenue Forecast by Regions 2019-2025
12.2 Antibody Drug Conjugates Market Forecast by Product
12.2.1 Global Antibody Drug Conjugates Sales Forecast by Product 2019-2025
12.2.2 Global Antibody Drug Conjugates Revenue Forecast by Product 2019-2025
12.3 Antibody Drug Conjugates Market Forecast by End User
12.4 North America Antibody Drug Conjugates Forecast
12.5 Europe Antibody Drug Conjugates Forecast
12.6 Asia Pacific Antibody Drug Conjugates Forecast
12.7 Central & South America Antibody Drug Conjugates Forecast
12.8 Middle East and Africa Antibody Drug Conjugates Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody Drug Conjugates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Antibody Drug Conjugates Product Picture
Table Antibody Drug Conjugates Market Segments
Table Key Manufacturers Antibody Drug Conjugates Covered
Table Global Antibody Drug Conjugates Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Antibody Drug Conjugates Sales Market Share by Product 2014-2025
Figure Adcetris Product Picture
Table Major Manufacturers of Adcetris
Figure Kadcyla Product Picture
Table Major Manufacturers of Kadcyla
Table Global Antibody Drug Conjugates Market Size Growth Rate by End User 2019-2025 (MT)
Figure Breast Cancer
Figure Lymphoma
Figure Antibody Drug Conjugates Report Years Considered
Figure Global Antibody Drug Conjugates Market Size 2014-2025 (Million US$)
Figure Global Antibody Drug Conjugates Sales 2014-2025 (MT)
Table Global Antibody Drug Conjugates Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Antibody Drug Conjugates Sales by Regions 2014-2019 (MT)
Table Global Antibody Drug Conjugates Sales Market Share by Regions 2014-2019
Figure Global Antibody Drug Conjugates Sales Market Share by Regions 2014-2019
Figure 2018 Global Antibody Drug Conjugates Sales Market Share by Regions
Table Global Antibody Drug Conjugates Revenue by Regions 2014-2019 (Million US$)
Table Global Antibody Drug Conjugates Revenue Market Share by Regions 2014-2019
Figure Global Antibody Drug Conjugates Revenue Market Share by Regions 2014-2019
Figure 2018 Global Antibody Drug Conjugates Revenue Market Share by Regions
Table Global Antibody Drug Conjugates Sales by Manufacturers (2014-2019) (MT)
Table Global Antibody Drug Conjugates Sales Share by Manufacturers (2014-2019)
Figure Global Antibody Drug Conjugates Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antibody Drug Conjugates Revenue by Manufacturers (2014-2019) (Million USD)
Table Antibody Drug Conjugates Revenue Share by Manufacturers (2014-2019)
Figure Antibody Drug Conjugates Value Share by Manufacturers in 2018
Table Key Manufacturers Antibody Drug Conjugates Price (2014-2019) (USD/Kg)
Table Antibody Drug Conjugates Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antibody Drug Conjugates Product Type
Table Date of International Manufacturers Enter into Antibody Drug Conjugates Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antibody Drug Conjugates Sales by Product (2014-2019) (MT)
Table Global Antibody Drug Conjugates Sales Share by Product (2014-2019)
Figure Global Antibody Drug Conjugates Sales Market Share by Product (2014-2019)
Figure Global Antibody Drug Conjugates Sales Market Share by Product in 2018
Table Global Antibody Drug Conjugates Revenue by Product (2014-2019) (Million US$)
Table Global Antibody Drug Conjugates Revenue Share by Product (2014-2019)
Figure Global Antibody Drug Conjugates Revenue Market Share by Product (2014-2019)
Figure Global Antibody Drug Conjugates Revenue Market Share by Product in 2018
Table Antibody Drug Conjugates Price by Product 2014-2019 (USD/Kg)
Table Global Antibody Drug Conjugates Sales by End User (2014-2019) (MT)
Table Global Antibody Drug Conjugates Sales Share by End User (2014-2019)
Figure Global Sales Antibody Drug Conjugates Market Share by End User (2014-2019)
Figure Global Sales Antibody Drug Conjugates Market Share by End User in 2018
Figure North America Antibody Drug Conjugates Sales Growth Rate 2014-2019 (MT)
Figure North America Antibody Drug Conjugates Revenue Growth Rate 2014-2019 (Million US$)
Table North America Antibody Drug Conjugates Sales by Countries (2014-2019) (MT)
Table North America Antibody Drug Conjugates Sales Market Share by Countries (2014-2019)
Figure 2018 North America Antibody Drug Conjugates Sales Market Share by Countries
Table North America Antibody Drug Conjugates Revenue by Countries (2014-2019) (Million US$)
Table North America Antibody Drug Conjugates Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Antibody Drug Conjugates Revenue Market Share by Countries
Figure United States Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure United States Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (MT)
Figure Canada Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Canada Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Mexico Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Table North America Antibody Drug Conjugates Sales by Product (2014-2019) (MT)
Table North America Antibody Drug Conjugates Sales Market Share by Product (2014-2019)
Figure 2018 North America Antibody Drug Conjugates Market Share by Product
Table North America Antibody Drug Conjugates Sales by End User (2014-2019) (MT)
Table North America Antibody Drug Conjugates Sales Market Share by End User (2014-2019)
Figure 2018 North America Antibody Drug Conjugates Market Share by End User
Figure Europe Antibody Drug Conjugates Sales Growth Rate 2014-2019 (MT)
Figure Europe Antibody Drug Conjugates Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Antibody Drug Conjugates Sales by Countries (2014-2019) (MT)
Table Europe Antibody Drug Conjugates Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Antibody Drug Conjugates Sales Market Share by Countries
Table Europe Antibody Drug Conjugates Revenue by Countries (2014-2019) (Million US$)
Table Europe Antibody Drug Conjugates Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Antibody Drug Conjugates Revenue Market Share by Countries
Figure Germany Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Germany Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure France Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure France Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure UK Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Italy Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Russia Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Antibody Drug Conjugates Sales by Product (2014-2019) (MT)
Table Europe Antibody Drug Conjugates Sales Market Share by Product (2014-2019)
Figure 2018 Europe Antibody Drug Conjugates Market Share by Product
Table Europe Antibody Drug Conjugates Sales by End User (2014-2019) (MT)
Table Europe Antibody Drug Conjugates Sales Market Share by End User (2014-2019)
Figure 2018 Europe Antibody Drug Conjugates Market Share by End User
Figure Asia Pacific Antibody Drug Conjugates Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Antibody Drug Conjugates Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Antibody Drug Conjugates Sales by Countries (2014-2019) (MT)
Table Asia Pacific Antibody Drug Conjugates Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antibody Drug Conjugates Sales Market Share by Countries
Table Asia Pacific Antibody Drug Conjugates Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Antibody Drug Conjugates Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antibody Drug Conjugates Revenue Market Share by Countries
Figure China Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure China Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Japan Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Korea Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure India Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure India Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Australia Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Philippines Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Thailand Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Singapore Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Antibody Drug Conjugates Sales by Product (2014-2019) (MT)
Table Asia Pacific Antibody Drug Conjugates Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Antibody Drug Conjugates Market Share by Product
Table Asia Pacific Antibody Drug Conjugates Sales by End User (2014-2019) (MT)
Table Asia Pacific Antibody Drug Conjugates Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Antibody Drug Conjugates Market Share by End User
Figure Central & South America Antibody Drug Conjugates Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Antibody Drug Conjugates Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Antibody Drug Conjugates Sales by Countries (2014-2019) (MT)
Table Central & South America Antibody Drug Conjugates Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antibody Drug Conjugates Sales Market Share by Countries
Table Central & South America Antibody Drug Conjugates Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Antibody Drug Conjugates Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antibody Drug Conjugates Revenue Market Share by Countries
Figure Brazil Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Brazil Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Argentina Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Antibody Drug Conjugates Sales by Product (2014-2019) (MT)
Table Central & South America Antibody Drug Conjugates Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Antibody Drug Conjugates Market Share by Product
Table Central & South America Antibody Drug Conjugates Sales by End User (2014-2019) (MT)
Table Central & South America Antibody Drug Conjugates Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Antibody Drug Conjugates Market Share by End User
Figure Middle East and Africa Antibody Drug Conjugates Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Antibody Drug Conjugates Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Antibody Drug Conjugates Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Antibody Drug Conjugates Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antibody Drug Conjugates Sales Market Share by Countries
Table Middle East and Africa Antibody Drug Conjugates Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Antibody Drug Conjugates Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antibody Drug Conjugates Revenue Market Share by Countries
Figure GCC Countries Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Turkey Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure Egypt Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Antibody Drug Conjugates Sales Growth Rate (2014-2019) (MT)
Figure South Africa Antibody Drug Conjugates Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Antibody Drug Conjugates Sales by Product (2014-2019) (MT)
Table Middle East and Africa Antibody Drug Conjugates Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Antibody Drug Conjugates Market Share by Product
Table Middle East and Africa Antibody Drug Conjugates Sales by End User (2014-2019) (MT)
Table Middle East and Africa Antibody Drug Conjugates Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Antibody Drug Conjugates Market Share by End User
Table F. Hoffman-La Roche Company Details
Table F. Hoffman-La Roche Antibody Drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table F. Hoffman-La Roche Recent Development
Table Novartis AG Company Details
Table Novartis AG Antibody Drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Novartis AG Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Antibody Drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Pfizer Company Details
Table Pfizer Antibody Drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Seattle Genetics Company Details
Table Seattle Genetics Antibody Drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Seattle Genetics Recent Development
Table Genentech Company Details
Table Genentech Antibody Drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Genentech Recent Development
Table Immunogen Company Details
Table Immunogen Antibody Drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Immunogen Recent Development
Table Progenics Pharmaceuticals Company Details
Table Progenics Pharmaceuticals Antibody Drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Progenics Pharmaceuticals Recent Development
Table Bayer Healthcare Pharmaceuticals Company Details
Table Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Bayer Healthcare Pharmaceuticals Recent Development
Table Global Antibody Drug Conjugates Sales Forecast by Regions 2019-2025 (MT)
Table Global Antibody Drug Conjugates Sales Market Share Forecast by Regions 2019-2025
Table Global Antibody Drug Conjugates Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Antibody Drug Conjugates Revenue Market Share Forecast by Regions 2019-2025
Table Global Antibody Drug Conjugates Sales Forecast by Product 2019-2025 (MT)
Table Global Antibody Drug Conjugates Sales Market Share Forecast by Product 2019-2025
Table Global Antibody Drug Conjugates Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Antibody Drug Conjugates Revenue Market Share Forecast by Product 2019-2025
Table Global Antibody Drug Conjugates Sales Forecast by End User 2019-2025 (MT)
Table Global Antibody Drug Conjugates Sales Market Share Forecast by End User 2019-2025
Figure North America Antibody Drug Conjugates Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Antibody Drug Conjugates Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Antibody Drug Conjugates Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Antibody Drug Conjugates Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Antibody Drug Conjugates Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Antibody Drug Conjugates Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Antibody Drug Conjugates Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Antibody Drug Conjugates Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Antibody Drug Conjugates Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Antibody Drug Conjugates Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Antibody Drug Conjugates Value Chain
Table Antibody Drug Conjugates Customers List
Table Antibody Drug Conjugates Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
次世代抗体療法の世界市場：市場規模・現状・予測 The ADCs segment held the largest market share in the historical period and is projected to hold a market share of over 50% by 2025. The Fc engineered antibodies segmented is projected to witness the fastest growth during the forecast period.Geographically, North America dominates the next-generatio…- モノクローナル抗体治療薬の世界市場：インサイト・予測 For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body.T…
- モノクローナル抗体ベース製品の世界市場：市場規模・現状・予測 Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins. This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodie…
- バイオシミラーモノクローナル抗体の世界市場：市場規模・現状・予測 Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthriti…
- 抗体ライブラリ技術の世界市場：市場規模・現状・予測 The main idea of antibody library technology is to clone all the antibody variable region genes of an animal into plasmids or phage, and use different antigens to screen out clones carrying specific antibody genes to obtain corresponding specific antibodies.Demand for antibody library technologies i…